Biotech · Private company
Ambry Genetics
Track this companyFree. Adds Ambry Genetics to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Multi-gene Next Generation Sequencing PanelPancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- RT-PCRRNA Virus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate CancersNA · COMPLETED · started Dec 1, 2020ClinicalTrials.gov NCT04330716 · fetched Nov 12, 2026
- COVID-19 and SARS-CoV-2 Detection in SalivaCOMPLETED · started May 21, 2020ClinicalTrials.gov NCT04517682 · fetched Nov 12, 2026
- Clinical Implementation of a Polygenic Risk Score (PRS) for Breast CancerCOMPLETED · started Sep 21, 2018ClinicalTrials.gov NCT03688204 · fetched Nov 12, 2026
- Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic CancerCOMPLETED · started May 4, 2016ClinicalTrials.gov NCT02790944 · fetched Nov 12, 2026